{"transactions":[{"id":3007820,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-13T15:54:21.000Z","date":"2020-10-12","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":5.39,"value":1078000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $1,078,000.00, representing the difference between the exercise price of the option and the acquisition price of $18.15."}],"balance_after":0,"derivative":{"exercise_price":12.76,"expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-054613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120054613/doc4.xml","form_type":"4"}},{"id":3007819,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-13T15:54:21.000Z","date":"2020-10-12","kind":"disposition_to_issuer","acquired":false,"shares":120000,"price":5.39,"value":646800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $646,800.00, representing the difference between the exercise price of the option and the acquisition price of $18.15."}],"balance_after":0,"derivative":{"exercise_price":12.76,"expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-20-054613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120054613/doc4.xml","form_type":"4"}},{"id":3007818,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-13T15:54:21.000Z","date":"2020-10-12","kind":"other","acquired":false,"shares":242978,"price":18.15,"value":4410050.7,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-054613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120054613/doc4.xml","form_type":"4"}},{"id":3022756,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-24T16:19:25.000Z","date":"2020-09-22","kind":"sale","acquired":false,"shares":8709,"price":18.12,"value":157807.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on September 19, 2019."}],"balance_after":242978,"source":{"system":"sec-edgar","filing":"0001209191-20-051888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120051888/doc4.xml","form_type":"4"}},{"id":3040600,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-02T16:20:43.000Z","date":"2020-08-31","kind":"grant","acquired":true,"shares":1104,"price":14.399,"value":15896.496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Although not required, the Reporting Person is voluntarily reporting the acquisition of 1,104 shares on August 31, 2020 pursuant to the Issuer's\nEmployee Stock Purchase Plan."}],"balance_after":251687,"source":{"system":"sec-edgar","filing":"0001209191-20-049120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120049120/doc4.xml","form_type":"4"}},{"id":3190405,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-31T20:41:34.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Due to a typographical error, the number of shares was incorrectly reported on the original Form 4 as 109,800 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares vest as follows: 1/4th of the shares vest one year after March 19, 2020;1/48th of the shares vest monthly thereafter over the next three years."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Due to a typographical error, the number of shares was incorrectly reported on the original Form 4 as 109,800 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Due to a typographical error, the number of shares was incorrectly reported on the original Form 4 as 109,800 shares."}],"balance_after":120000,"derivative":{"exercise_price":12.76,"expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-20-021951","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120021951/doc4a.xml","form_type":"4/A","original_submission_date":"2020-03-23"}},{"id":3190404,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-31T20:41:34.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Due to a typographical error, the number of shares was incorrectly reported on the original Form 4 as 55,200 shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan."}],"balance_after":260000,"source":{"system":"sec-edgar","filing":"0001209191-20-021951","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120021951/doc4a.xml","form_type":"4/A","original_submission_date":"2020-03-23"}},{"id":3194930,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-25T16:41:05.000Z","date":"2020-03-23","kind":"sale","acquired":false,"shares":9417,"price":11.7499,"value":110648.8083,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on September 19, 2019."}],"balance_after":245783,"source":{"system":"sec-edgar","filing":"0001209191-20-021118","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120021118/doc4.xml","form_type":"4"}},{"id":3197586,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-23T16:22:25.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest as follows: 1/4th of the shares vest one year after March 19, 2020; 1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":200000,"derivative":{"exercise_price":12.76,"expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-20-020632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120020632/doc4.xml","form_type":"4"}},{"id":3197585,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-23T16:22:25.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":109800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest as follows: 1/4th of the shares vest one year after March 19, 2020; 1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":109800,"derivative":{"exercise_price":12.76,"expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":109800},"source":{"system":"sec-edgar","filing":"0001209191-20-020632","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120020632/doc4.xml","form_type":"4"}},{"id":3197584,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-23T16:22:25.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":55200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan."}],"balance_after":255200,"source":{"system":"sec-edgar","filing":"0001209191-20-020632","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919120020632/doc4.xml","form_type":"4"}},{"id":3407566,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Executive Office"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-23T17:22:17.000Z","date":"2019-09-19","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest as follows: 1/4th of the shares vest one year after September 19, 2019; 1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":400000,"derivative":{"exercise_price":22.46,"expiration_date":"2029-09-18","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-19-050481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919119050481/doc4.xml","form_type":"4"}},{"id":3407565,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Chief Executive Office"}}],"security":"Common Stock","published_at":"2019-09-23T17:22:17.000Z","date":"2019-09-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001209191-19-050481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662524/000120919119050481/doc4.xml","form_type":"4"}},{"id":3460307,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-07-17T21:39:11.000Z","date":"2019-07-15","kind":"exercise","acquired":false,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs vest in four equal annual installments.  Upon vesting, the RSUs will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs vest in four equal annual installments.  Upon vesting, the RSUs will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":3542},"source":{"system":"sec-edgar","filing":"0000874015-19-000114","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000114/edgar.xml","form_type":"4"}},{"id":3460306,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-07-17T21:39:11.000Z","date":"2019-07-15","kind":"tax_withholding","acquired":false,"shares":1225,"price":67.86,"value":83128.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice."},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice."}],"balance_after":2573,"source":{"system":"sec-edgar","filing":"0000874015-19-000114","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000114/edgar.xml","form_type":"4"}},{"id":3460305,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-07-17T21:39:11.000Z","date":"2019-07-15","kind":"exercise","acquired":true,"shares":3542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit (\"RSU\") awards."},{"field":"shares","element":"transactionShares","label":"F1","text":"Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit (\"RSU\") awards."}],"balance_after":3798,"source":{"system":"sec-edgar","filing":"0000874015-19-000114","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000114/edgar.xml","form_type":"4"}},{"id":3472944,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-07-03T00:35:14.000Z","date":"2019-07-01","kind":"other","acquired":true,"shares":256,"price":45.7045,"value":11700.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reporting 256 shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on July 1, 2019. These 256 shares may not be sold until January 2, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting 256 shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on July 1, 2019. These 256 shares may not be sold until January 2, 2020."}],"balance_after":256,"source":{"system":"sec-edgar","filing":"0000874015-19-000081","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000081/edgar.xml","form_type":"4"}},{"id":3694031,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2019-01-18T00:23:26.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":13065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments.  Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments.  Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":13065,"derivative":{"underlying":"Common Stock","underlying_shares":13065},"source":{"system":"sec-edgar","filing":"0000874015-19-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000018/edgar.xml","form_type":"4"}},{"id":3711019,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-04T00:46:58.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":29400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of 01/02/2019 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 01/02/2020. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments over the next 3 years. Following this transaction, the option was exercisable as to 0 on 01/02/2019."}],"balance_after":29400,"derivative":{"exercise_price":53.77,"exercise_date":"2020-01-02","expiration_date":"2026-01-01","underlying":"Common Stock","underlying_shares":29400},"source":{"system":"sec-edgar","filing":"0000874015-19-000012","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401519000012/edgar.xml","form_type":"4"}},{"id":3867563,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units","published_at":"2018-07-16T22:58:26.000Z","date":"2018-07-15","kind":"grant","acquired":true,"shares":14167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company."}],"balance_after":14167,"derivative":{"underlying":"Common Stock","underlying_shares":14167},"source":{"system":"sec-edgar","filing":"0000874015-18-000099","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401518000099/edgar.xml","form_type":"4"}},{"id":3891587,"issuer":{"id":1182,"kind":"organization","name":"IONIS PHARMACEUTICALS INC","symbol":"IONS"},"owners":[{"id":145991,"kind":"person","name":"McDevitt Damien","position":1,"cik":"0001742277","reported_name":"McDevitt Damien","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-06-18T22:33:21.000Z","date":"2018-06-18","kind":"grant","acquired":true,"shares":63750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of 6/18/2018 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 6/18/2019. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments over the next 3 years. Following this transaction, the option was exercisable as to 0 on 6/18/2018."}],"balance_after":63750,"derivative":{"exercise_price":43.6,"exercise_date":"2019-06-18","expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":63750},"source":{"system":"sec-edgar","filing":"0000874015-18-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874015/000087401518000071/edgar.xml","form_type":"4"}}]}